Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), signaling represent potential therapeutic targets for major depressive disorder. The purpose of this study is to examine whether TrkB ligands show antidepressant effects in an inflammation-induced model of depression. METHODS: In this study, we examined the effects of TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) and TrkB antagonist ANA-12 on depression-like behavior and morphological changes in mice previously exposed to lipopolysaccharide (LPS). Protein levels of BDNF, phospho-TrkB (p-TrkB), and TrkB in the brain regions were also examined. RESULTS: LPS caused a reduction of BDNF in the CA3 and dentate gyrus (DG) of the hippocampus and prefrontal cortex (PFC), whereas LPS increased BDNF in the nucleus accumbens (NAc). Dexamethason suppression tests showed hyperactivity of the hypothalamic-pituitary-adrenal axis in LPS-treated mice. Intraperitoneal (i.p.) administration of 7,8-DHF showed antidepressant effects on LPS-induced depression-like behavior, and i.p. pretreatment with ANA-12 blocked its antidepressant effects. Surprisingly, ANA-12 alone showed antidepressant-like effects on LPS-induced depression-like behavior. Furthermore, bilateral infusion of ANA-12 into the NAc showed antidepressant effects. Moreover, LPS caused a reduction of spine density in the CA3, DG, and PFC, whereas LPS increased spine density in the NAc. Interestingly, 7,8-DHF significantly attenuated LPS-induced reduction of p-TrkB and spine densities in the CA3, DG, and PFC, whereas ANA-12 significantly attenuated LPS-induced increases of p-TrkB and spine density in the NAc. CONCLUSIONS: The results suggest that LPS-induced inflammation may cause depression-like behavior by altering BDNF and spine density in the CA3, DG, PFC, and NAc, which may be involved in the antidepressant effects of 7,8-DHF and ANA-12, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Blockade of NLRP3 reverses stress-induced increases in IL-1β in the peripheral blood and brain, while also abrogating depressive-like behaviour in mice45.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [45]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“studies in laboratory animals indicate that chronic mild-stress activates the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, which is well-known to respond to DAMPs44,45.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 4×
“Peripheral administration of LPS induces sickness behavior that peaks after two to six hours, then gradually wanes (Dantzer et al., 2008).”
BackgroundInfluentialPhysiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 2×
“Changes in dendritic length and spine density in the hippocampus and PFC are thought to contribute to the neurobiology of MDD, and antidepressant treatment is mediated, in part, by blocking or reversing these changes (McEwen, 2007; Duman and Aghajanian, 2012).”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Meta-analysis shows higher blood levels of pro-inflammatory cytokines in drug-free MDD patients, compared with healthy controls (Dowlati et al., 2010).”
BackgroundThe mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045 · cited 4×
“Microinjection needles were placed bilaterally into the NAc shell (+1.7 AP, ±0.75 ML, -3.6 DV) (Paxinos and Watson, 1998).”
MethodInfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Accumulating evidence suggests that inflammatory processes play a role in the pathophysiology of major depressive disorder (MDD; Dantzer et al., 2008; Hashimoto, 2009; Miller et al., 2009; Raison et al., 2010).”
BackgroundThe Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 3×
“…signaling to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007; Hashimoto, 2010; Hashimoto, 2011, 2013a; Duman et al., 2012; Castrén, 2014; Lindholm and…”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Cited by
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
BDNF signaling in context: From synaptic regulation to psychiatric disorders
Wang, C. S., Kavalali, E. T., & Monteggia, L. M. (2022) · Cell · doi:10.1016/j.cell.2021.12.003 · Cited by 607
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605
Self-citationZhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094646 · Cited by 538
“We found that similar to ketamine, a single administration of TrkB ligands (7,8-DHF and ANA-12) conferred a rapid antidepressant effect in the social defeat stress model of depression [124].”
InfluentialSelf-citationAnimal models of major depression: drawbacks and challenges
Planchez, B., Surget, A., & Belzung, C. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02084-y · Cited by 480
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
“…a lower activity of dorsolateral PFC in resting state analyses of MDD patients (Fitzgerald et al. 2008; Hamilton et al. 2012; Limon et al. 2016; Zhang et al. 2015a; Zhong et al. 2016), meta-analyses of this region during task processing and especially in response to emotional stimuli with a…”
BackgroundDu, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 205
“BDNF signals downstream via the TrkB receptor and selective receptor agonists such as 7,8-dihdyroxyflavone are well established to exert anti-depressive effects (161, 162).”
BackgroundZhang, J., Ma, L., Chang, L., Pu, Y., Qu, Y., & Hashimoto, K. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00878-3 · Cited by 208
Self-citationMicroglial ERK-NRBP1-CREB-BDNF Signaling in Sustained Antidepressant Actions of (R)-Ketamine
Yao, W., Cao, Q., Luo, S., He, L., Yang, C., Chen, J., Qi, Q., Hashimoto, K., & Zhang, J.-C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01377-7 · Cited by 216
Self-citationBrain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
Porter, G. A., & O’Connor, J. C. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i1.77 · Cited by 178
Zhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., & Hashimoto, K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4062-3 · Cited by 183
“Nevertheless, drug dosages used are consistent with those used for the same drugs previously (Berton et al. 2006; Cazorla et al. 2011; Zhang et al. 2015; Ren et al. 2013, 2014; Li et al. 2014).”
BackgroundMethodResultInfluentialSelf-citationZhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., & Hashimoto, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.112 · Cited by 182
Self-citationPu, Y., Tan, Y., Qu, Y., Chang, L., Wang, S., Wei, Y., Wang, X., & Hashimoto, K. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.032 · Cited by 170
Self-citationInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Remus, J. L., & Dantzer, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw028 · Cited by 164
“It is also important to mention that mechanisms other than the kynurenine metabolites are being investigated in the inflammation-induced depression model, including brain derived neurotrophic factor (Zhang et al., 2014), leptin (Kurosawa et al.”
BackgroundRen, Q., Ma, M., Ishima, T., Morisseau, C., Yang, J., Wagner, K. M., Zhang, J.-C., Yang, C., Yao, W., Dong, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601532113 · Cited by 162
“Interestingly, current antidepressants (paroxetine and venlafaxine) do not have any effect in the LPS-induced inflammation model of depression (36).”
BackgroundSelf-citationYang, C., Qu, Y., Abe, M., Nozawa, D., Chaki, S., & Hashimoto, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.020 · Cited by 162
Self-citationLiu, W., Wang, J., Xie, Z.-M., Xu, N., Zhang, G.-F., Jia, M., Zhou, Z., Hashimoto, K., & Yang, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4128-2 · Cited by 169
Self-citationWang, Y.-L., Wu, H., Zhang, S., Xiao, H., Yu, J. M., Ma, Y.-Y., Zhang, Y., & Liu, Q. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01468-7 · Cited by 166
Yao, W., Zhang, J.-C., Ishima, T., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Suganuma, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30659 · Cited by 154
Self-citationInflammatory Biomarkers as Differential Predictors of Antidepressant Response
Hashimoto, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047796 · Cited by 137
“When bacterial endotoxin lipopolysaccharide (LPS) is administered to rodents, depression-like behaviors are induced after the induction of inflammation [8–11].”
BackgroundSelf-citationShirayama, Y., Yang, C., Zhang, J.-C., Ren, Q., Yao, W., & Hashimoto, K. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.002 · Cited by 137
Self-citationThe Microbiota-Inflammasome Hypothesis of Major Depression
Inserra, A., Rogers, G. B., Licinio, J., & Wong, M. (2018) · BioEssays · doi:10.1002/bies.201800027 · Cited by 134
AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine
Yang, C., Kobayashi, S., Nakao, K., Dong, C., Han, M., Qu, Y., Ren, Q., Zhang, J.-C., Ma, M., Toki, H., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.007 · Cited by 125
Self-citationMolecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs · doi:10.1007/s40263-021-00877-y · Cited by 127
“demonstrated that lipopolysaccharide-induced inflammation in mice resulted in a depression-like phenotype due to alterations in the BDNF-TrkB signaling pathway within the CA3 and dentate gyrus regions of the hippocampus as well as in the PFC and nucleus accumbens [113].”
BackgroundDong, C., Zhang, J.-C., Yao, W., Ren, Q., Ma, M., Yang, C., Chaki, S., & Hashimoto, K. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw089 · Cited by 116
“In contrast, we found increased spine density in the NAc of depressed mice after social defeat stress, consistent with results from the inflammation and learned helplessness models (Zhang et al., 2015a; Yang et al., 2015b, 2016b).”
BackgroundResultSelf-citationWang, D., Wu, J., Zhu, P., Xie, H., Lu, L., Bai, W., Pan, W., Shi, R., Ye, J., Xia, B., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111289 · Cited by 126
Self-citationZhang, K., Yang, C., Chang, L., Sakamoto, A., Suzuki, T., Fujita, Y., Qu, Y., Wang, S., Pu, Y., Tan, Y., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0733-x · Cited by 119
Self-citationZhang, J., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Ushida, Y., Suganuma, H., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.004 · Cited by 116
Self-citationGuan, Y., Huang, G., Xu, M.-D., Gao, F., Lin, S., Huang, J., Wang, J., Li, Y., Wu, C.-H., Yao, S., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.032 · Cited by 116
Yao, W., Lin, S., Su, J. Y., Cao, Q., Chen, Y., Chen, J., Zhang, Z., Hashimoto, K., Qi, Q., & Zhang, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01261-6 · Cited by 114
Self-citation(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Yamaguchi, J.-I., Toki, H., Qu, Y., Yang, C., Koike, H., Hashimoto, K., Mizuno-Yasuhira, A., & Chaki, S. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0084-y · Cited by 105
Self-citationHuang, N., Hua, D., Zhan, G., Li, S., Zhu, B., Jiang, R., Yang, L., Bi, J., Xu, H., Hashimoto, K., et al. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.001 · Cited by 103
Self-citationYang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu121 · Cited by 103
“The VTA–NAc pathway and BDNF in the NAc play a key role in the pathophysiology of depression (Nestler and Carlezon, 2006; Shirayama and Chaki, 2006; Krishnan et al., 2007; Zhang et al., 2015).”
BackgroundSelf-citationRetractedRen, Q., Ma, M., Yang, C., Zhang, J.-C., Yao, W., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.157 · Cited by 100
Self-citationEssential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
Hashimoto, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01182 · Cited by 98
“, 2016b), LPS-treated mice (Zhang et al., 2014) and CSDS susceptible mice (Zhang et al.”
BackgroundSelf-citationRole of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
Hashimoto, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00036 · Cited by 100
“(2016) reported that the sEH inhibitor TPPU [1-(1propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea] (Figure 2) conferred prophylactic and antidepressant effects in the LPS-induced inflammation model of depression while the current antidepressants showed no therapeutic effects in this model (Zhang et al., 201…”
BackgroundSelf-citationRéus, G. Z., Manosso, L. M., Quevedo, J., & Carvalho, A. F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105425 · Cited by 103
Ago, Y., Tanabe, W., Higuchi, M., Tsukada, S., Tanaka, T., Yamaguchi, T., Igarashi, H., Yokoyama, R., Seiriki, K., Kasai, A., et al. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz041 · Cited by 92
Self-citationShirai, Y., Fujita, Y., Hashimoto, R., Ohi, K., Yamamori, H., Yasuda, Y., Ishima, T., Suganuma, H., Ushida, Y., Takeda, M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127244 · Cited by 88
“, Columbia, MD, USA), following the manufacturer's instructions, as previously reported [29, 30].”
MethodSelf-citationYang, B., Zhang, J.-C., Han, M., Yao, W., Yang, C., Ren, Q., Ma, M., Chen, Q.-X., & Hashimoto, K. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4399-2 · Cited by 91
“We recently reported that TrkB agonist 7,8-DHF and TrkB antagonist ANA-12 showed antidepressant activity on inflammation (or social defeat stress)-induced depressive behavior, by normalizing altered dendritic spines in the PFC and hippocampus and NAc, respectively (Zhang et al. 2015a; 2015b).”
BackgroundMethodResultInfluentialSelf-citationTalebi, M., Talebi, M., Farkhondeh, T., Kopustinskienė, D. M., Simal‐Gándara, J., Bernatonienė, J., & Samarghandian, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111906 · Cited by 90
How Oxidative Stress Induces Depression?
Ji, N., Lei, M., Chen, Y., Tian, S., Li, C., & Zhang, B. (2023) · ASN NEURO · doi:10.1177/17590914231181037 · Cited by 92
“…DLB Autry et al. (2011) BDNF/TrkB dysfunction Mice/ Rats CUMS and CSDS reduced BDNF expression in PFC/ hippocampus, and induced DLB Mao et al. (2009); Zhang et al. (2015) Ketamine and its metabolite increased BDNF in mPFC, which was required for antidepressant action Fukumoto et al. (2019;…”
BackgroundBhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 88
Gliwińska, A., Czubilińska-Łada, J., Więckiewicz, G., Świętochowska, E., Badeński, A., Dworak, M., & Szczepańska, M. (2023) · Brain Sciences · doi:10.3390/brainsci13020163 · Cited by 93
“Furthermore, the peripheral infusion of BDNF causes hyperalgesia, which is an additional limitation to the use of BDNF in the form of infusions [74,75].”
BackgroundSun, H.-L., Zhou, Z.-Q., Zhang, G.-F., Yang, C., Wang, X.-M., Shen, J.-C., Hashimoto, K., & Yang, J.-J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.21 · Cited by 84
Self-citationEffects of hydrogen-rich water on depressive-like behavior in mice
Zhang, Y., Su, W.-J., Chen, Y., Wu, T.-Y., Gong, H., Shen, X.-L., Wang, Y.-X., Sun, X.-J., & Jiang, C.-L. (2016) · Scientific Reports · doi:10.1038/srep23742 · Cited by 79
Parrini, M., Ghezzi, D., Deidda, G., Medrihan, L., Castroflorio, E., Alberti, M., Baldelli, P., Cancedda, L., & Contestabile, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17201-8 · Cited by 73
Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder
Innes, S., Pariante, C. M., & Borsini, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.233 · Cited by 75
Yan, T., He, B., Wan, S., Xu, M., Yang, H., Xiao, F., Bi, K., & Jia, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-07407-1 · Cited by 80
Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors
Wang, Y., Ni, J., Zhai, L., Gao, C., Xie, L., Zhao, L., & Yin, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.015 · Cited by 75
Xie, Z.-M., Wang, X.-M., Xu, N., Wang, J., Pan, W., Tang, X.-H., Zhou, Z.-Q., Hashimoto, K., & Yang, J.-J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03590-3 · Cited by 71
Self-citationProwse, N. A., & Hayley, S. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.018 · Cited by 78
Yang, B., Yang, C., Ren, Q., Zhang, J.-C., Chen, Q., Shirayama, Y., & Hashimoto, K. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0693-6 · Cited by 74
Self-citationFinnell, J. E., & Wood, S. K. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.04.001 · Cited by 67
“Furthermore, administration of pro-inflammatory agents induce depressive symptoms in patients with no history of depression and in laboratory animals (O'Connor et al., 2009b; Schmeler et al., 2009; Kaster et al., 2012; Ji et al., 2014; Zhang et al., 2015; Zhu et al., 2015).”
InfluentialMatisz, C. E., & Gruber, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.020 · Cited by 74
Adetuyi, B. O., & Farombi, E. O. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13660 · Cited by 76
Zhang, J.-C., Yao, W., Ren, Q., Yang, C., Dong, C., Ma, M., Wu, J., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep36705 · Cited by 86
“Since increased BDNF-TrkB signaling in the NAc was shown in α 7 nAChR KO mice, we examined whether the TrkB antagonist ANA-12 31,33,34,36,42–44 could confer antidepressant effects in KO mice.”
InfluentialSelf-citationAnimal inflammation-based models of depression and their application to drug discovery
Ma, L., Demin, K. A., Kolesnikova, T. O., Kharsko, S. L., Zhu, X., Yuan, X., Song, C., Meshalkina, D. A., Leonard, B. E., Tian, L., et al. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1362385 · Cited by 68
Zhang, J., Ma, L., Wan, X., Shan, J., Qu, Y., & Hashimoto, K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05889-6 · Cited by 71
Self-citationKetamine and its metabolites: Potential as novel treatments for depression
Zhang, K., Yao, Y., & Hashimoto, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109305 · Cited by 72
Self-citationMa, M., Ren, Q., Yang, C., Zhang, J.-C., Yao, W., Dong, C., Ohgi, Y., Futamura, T., & Hashimoto, K. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4483-7 · Cited by 69
Self-citationRegional differences in dendritic spine density confer resilience to chronic social defeat stress
Qu, Y., Yang, C., Ren, Q., Ma, M., Dong, C., & Hashimoto, K. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.16 · Cited by 68
“The VTA-NAc pathway plays a key role in the pathophysiology of depression (11,12,16).”
BackgroundResultSelf-citationIbi, M., Liu, J., Arakawa, N., Kitaoka, S., Kawaji, A., Matsuda, K.-I., Iwata, K., Matsumoto, M., Katsuyama, M., Zhu, K., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2988-16.2017 · Cited by 65
“Spines were counted along dendrites starting from their point of origin from the primary dendrites (Zhang et al., 2014).”
BackgroundKeap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress
Zhang, J.-C., Yao, W., Dong, C., Han, M., Shirayama, Y., & Hashimoto, K. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0848-0 · Cited by 66
Self-citationRen, Z., Yan, P., Zhu, L.-S., Yang, H., Zhao, Y., Kirby, B. P., Waddington, J. L., & Zhen, X. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4761-z · Cited by 66
“The prefrontal cortex (Zhang et al. 2014) and nucleus accumbens (Yang et al. 2016) may also play a role in such experimental models.”
The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
Wang, J., Jia, Y., Li, G., Wang, B., Zhou, T., Zhu, L., Chen, T., & Chen, Y. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy005 · Cited by 62
“, 2015), and increased in the NAc (Krishnan et al., 2007; Zhang et al., 2014; Ma et al., 2017) has also been reported in patients with depression and inflammation-related depressive animal models.”
BackgroundResultChávez-Castillo, M., Núñez, V., Nava, M., Ortega, Á., Rojas, M., Bermúdez, V., & Rojas, J. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/7943481 · Cited by 71
“Paradoxically, this antagonist has also been linked with antidepressant and anxiolytic activity in mice models [99, 100].”
BackgroundAno, Y., Ohya, R., Kita, M., Taniguchi, Y., & Kondô, K. (2019) · Molecules · doi:10.3390/molecules24030467 · Cited by 65
“It has been reported that intracerebroventricular administration of LPS induces dendritic changes in the hippocampus and prefrontal cortex and depressive-like behavior, whereas suppression of inflammation can improve these impairments [31,32].”
BackgroundMethodMa, M., Ren, Q., Yang, C., Zhang, J.-C., Yao, W., Dong, C., Ohgi, Y., Futamura, T., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep39209 · Cited by 59
Self-citationLavender, E., Hirasawa-Fujita, M., & Domino, E. F. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112631 · Cited by 58
He, L., Zheng, Y., Huang, L., Ye, J., Ye, Y., Luo, H., Chen, X., Yao, W., Chen, J., & Zhang, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02227-y · Cited by 61
Self-citationThe Neurotrophic Hypothesis of Depression Revisited: New Insights and Therapeutic Implications
Jaggar, M., Fanibunda, S. E., Ghosh, S., Duman, R. S., & Vaidya, V. A. (2019) · Neurobiology of Depression · doi:10.1016/b978-0-12-813333-0.00006-8 · Cited by 54
Yang, S., & Zhu, G. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210915122820 · Cited by 60
“It suggested that the antidepressant effect of 7,8-DHF might be related to the improvement of the abnormality of dendritic spines in the hippocampus and PFC and the regulation of BDNF expression in the related brain regions [98].”
Huang, F., Liu, X., Xu, S., Hu, S., Wang, S., Shi, D., Wang, K., Wang, Z., Lin, Q., Li, S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.805465 · Cited by 63
“Systemic administration of proinflammatory cytokines IL-1β or LPS induced a notable reduction in hippocampal BDNF content in depressive rats (29, 30), with similar results that found in depressive patients exhibiting a decrease in neuroinflammation-induced BDNF (31).”
ResultSelf-citationAntidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
Su, W.-J., Peng, W., Gong, H., Liu, Y.-Z., Zhang, Y., Lian, Y.-J., Cao, Z.-Y., Wu, R., Liu, L.-L., Wang, B., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0985-4 · Cited by 54
Wang, G., Lei, C., Tian, Y., Wang, Y., Zhang, L., & Zhang, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01034 · Cited by 61
Miyanishi, H., & Nitta, A. (2021) · Pharmaceuticals · doi:10.3390/ph14090889 · Cited by 57
Advances in the Preclinical Study of Some Flavonoids as Potential Antidepressant Agents
Germán-Ponciano, L. J., Rosas-Sánchez, G. U., Rivadeneyra-Domínguez, E., & Rodríguez‐Landa, J. F. (2018) · Scientifica · doi:10.1155/2018/2963565 · Cited by 61
“Flavonoids produce pharmacological actions on the central nervous system (Table 2) to regulate emotional and mood states associated with plastic and neurochemical changes as is the case with conventional antidepressant drugs [9, 10, 38, 101].”
BackgroundMethodGawali, N. B., Bulani, V. D., Chowdhury, A. A., Deshpande, P. S., Nagmoti, D. M., & Juvekar, A. R. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.07.004 · Cited by 60
Zhang, J., Qu, Y., Chang, L., Pu, Y., & Hashimoto, K. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz048 · Cited by 55
Self-citationYang, Y. H., Eguchi, A., Wan, X., Chang, L., Wang, X., Qu, Y., Mori, C., & Hashimoto, K. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110652 · Cited by 55
Self-citationTurkin, A., Tuchina, O. P., & Klempin, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665739 · Cited by 55
Ma, L., Zhang, J., Fujita, Y., Qu, Y., Shan, J., Wan, X., Wang, X., Ishima, T., Kobayashi, K., Wang, L., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01803-6 · Cited by 57
“The procedure of LPStreated inflammation model for depression was performed as reported previously [35, 50, 57, 58].”
MethodSelf-citationBDNF receptor TrkB as the mediator of the antidepressant drug action
Casarotto, P., Umemori, J., & Castrén, E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1032224 · Cited by 50
Han, M., Zhang, J.-C., Yao, W., Yang, C., Ishima, T., Ren, Q., Ma, M., Dong, C., Huang, X., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep36087 · Cited by 57
Self-citationBarfield, E. T., & Gourley, S. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.015 · Cited by 53
Yao, W., Zhang, J.-C., Dong, C., Zhuang, C., Hirota, S., Inanaga, K., & Hashimoto, K. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.012 · Cited by 57
“The FST and TST in mice are the most widely used behavioral assays for detecting potential antidepressant-like activity (Cryan and Holmes, 2005; Ma et al., 2011, 2013, 2014; Zhang et al., 2015).”
MethodSelf-citationWu, Y., Luo, X., Liu, X., Liu, D., Wang, X., Guo, Z., Zhu, L., Tian, Q., Yang, X., & Wang, J.-Z. (2015) · Scientific Reports · doi:10.1038/srep15032 · Cited by 51
The hippocampus in stress susceptibility and resilience: Reviewing molecular and functional markers
Larosa, A., & Wong, T. P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110601 · Cited by 54
Sahin, C., Albayrak, O., Akdeniz, T. F., Akbulut, Z., Yanikkaya Demirel, G., & Aricioglu, F. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12604 · Cited by 50
Antidepressant drug action--From rapid changes on network function to network rewiring
Rantamäki, T., & Yalcin, I. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.001 · Cited by 50
Dong, C., Zhang, J.-C., Yao, W., Ren, Q., Yang, C., Ma, M., Han, M., Saito, R., & Hashimoto, K. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.02.005 · Cited by 53
Self-citationNakazawa, T., Hashimoto, R., Sakoori, K., Sugaya, Y., Tanimura, A., Hashimotodani, Y., Ohi, K., Yamamori, H., Yasuda, Y., Umeda-Yano, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10594 · Cited by 50
Zhang, F., Fu, Y.-Y., Zhou, X.-Y., Pan, W.-H., Shi, Y., Wang, M., Zhang, X., Qi, D.-S., Li, L., Ma, K., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.06.001 · Cited by 44
Ma, L., Zhang, J., Fujita, Y., Shinno-Hashimoto, H., Shan, J., Wan, X., Qu, Y., Chang, L., Wang, X., & Hashimoto, K. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.087 · Cited by 52
Self-citationLi, S., Luo, X., Hua, D., Wang, Y., Zhan, G., Huang, N., Jiang, R., Yang, L., Zhu, B., Yuan, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01702 · Cited by 49
“The doses of ketamine (10 mg/kg), 7,8-DHF (10 mg/kg), ANA-12 (0.5 mg/kg), and vehicle or saline (10 ml/kg) were selected as reported previously (Yang et al., Frontiers in Pharmacology | www.frontiersin.org 4 2013; Zhang et al., 2014; Fang et al., 2018).”
BackgroundMethodInfluentialSelf-citationHe, Y., Li, W., Wang, Y., Tian, Y., Chen, X., Wu, Z., Lan, T., Li, Y., Bai, M., Liu, J., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.131 · Cited by 48
Deyama, S., & Kaneda, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109335 · Cited by 49
Qu, Y., Chang, L., Ma, L., Wan, X., & Hashimoto, K. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173500 · Cited by 48
Self-citation
Metadata
- Authors
- Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-26
- Volume
- 18
- Issue
- 4
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC4360225
- OpenAlex
- W2055018912
- Cited by
- 289
- References
- 72
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 18 · 2023: 23 · 2022: 26 · 2021: 46 · 2020: 17 · 2019: 24 · 2018: 33 · 2017: 25 · 2016: 37 · 2015: 18
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Eli Lilly and Company
- Ministry of Education, Culture, Sports, Science and Technology (24116006)
- Astellas Pharma
- Chiba University
- SENSHIN Medical Research Foundation
- Japan Society for the Promotion of Science (24116006)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- TrkB signaling, brain-derived neurotrophic factor, antidepressant effects, depression-like behavior, lipopolysaccharide-induced inflammation, 7,8-dihydroxyflavone, ANA-12, dendritic spine density, hippocampus, prefrontal cortex, nucleus accumbens, hypothalamic-pituitary-adrenal axis, major depressive disorder
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Antidepressive Agents, Azepines, Benzamides, Depressive Disorder, Disease Models, Animal, Hippocampus, Lipopolysaccharides, Male, Mice, Inbred C57BL, Nucleus Accumbens, Phosphorylation, Prefrontal Cortex, Brain-Derived Neurotrophic Factor, Receptor, trkB, Multiprotein Complexes, Flavones, Dendritic Spines, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.